Tag: CDSCO
Roche Enters BTK Degrader Space with $2.3B Nurix Therapeutics Alliance
Roche and Nurix Therapeutics, Inc. announced a definitive global licensing and collaboration agreement to co-develop and co-commercialize bexobrutideg (NX-5948), an investigational, orally bioavailable Bruton’s Tyrosine Kinase (BTK) degrader. The transaction, valued...
CDSCO Tightens Action Against Banned Antibiotics After Shrimp Export Rejections Jump 43%
The Central Drugs Standard Control Organisation (CDSCO), under India's Ministry of Health and Family Welfare, has issued a directive to all State and Union...
Solaris Pharma Launches Generic Briviact®️ to Improve Access to Epilepsy Treatment
Solaris Pharma has launched brivaracetam tablets — the generic equivalent of UCB's Briviact® — marking a notable pivot for a company long anchored in...
XOCOVA®️ Becomes First-Ever Oral Pill Approved to Prevent COVID-19 After Exposure
A historic milestone in pandemic preparedness arrived this week as the U.S. Food and Drug Administration granted approval to XOCOVA® (ensitrelvir) — the world’s...
Surat Gets Major Healthcare Boost as PM Modi Inaugurates ₹216 Crore ESIC Hospital
Prime Minister Narendra Modi has officially inaugurated a newly upgraded, state-of-the-art 220-bedded Employees’ State Insurance Corporation (ESIC) Hospital in Surat, Gujarat. The virtual dedication...
Lupin Teams up with Laboratorios ERN to launch Luforbec®️ PMDI in the Spanish Market
Lupin Limited (Lupin) the Mumbai based Indian pharma major on 08th June announced its strategic collaboration with LABORATORIOS ERN S.A. (ERN), a renowned Spanish pharmaceutical company, for the launch of Luforbec® (beclometasone/formoterol) 100/6, a fixed...